The experimental vaccine developed by researchers from the National Institute of Allergy and Infectious Diseases is now moving into its second phase of testing and will include more than 2,000 volunteers from the US and other countries. Funding for the $100 million clinical trial has been secured despite the proposed $7 billion cuts from the budget of the NIH, according to NIAID Director Dr. Anthony Fauci. Click here for the full article on Reuters.
Click above button to access your child's medical record or email your doctor.
Don't have an account? Sign up using the Patient Portal Form.